XML 24 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Shareholders' Equity - CAD ($)
$ in Thousands
Issued capital [member]
Capital reserve [member]
Accumulated other comprehensive income [member]
Retained earnings [member]
Total
Balance (in shares) at Dec. 31, 2021 7,743,713        
Balance at Dec. 31, 2021 $ 276,215 $ 16,554 $ 525 $ (193,330) $ 99,964
Statement Line Items [Line Items]          
Net loss for the year 0 0 0 12,551 12,551
Share-based payment expense 0 1,282 0 0 1,282
Directors’ fees paid in deferred share units $ 0 115 0 0 115
Proceeds from issuance of shares, net of transaction costs (Note 13) (in shares) 180,216        
Proceeds from issuance of shares, net of transaction costs (Note 13) $ 3,701 0 0 0 $ 3,701
Exercise of share based payment arrangement (Note 13) (in shares) 89,039       89,039
Exercise of share based payment arrangement (Note 13) $ 1,439 (492) 0 0 $ 947
Convertible Notes Conversion (Notes 11 and 13) (in shares) 197,276        
Convertible Notes Conversion (Notes 11 and 13) $ 4,835 0 0 0 4,835
Cash, net of transaction costs and fair value derivative (Note 13) (in shares) 586,250        
Cash, net of transaction costs and fair value derivative (Note 13) $ 2,681 433 0 0 3,114
Balance (in shares) at Dec. 31, 2022 8,796,494        
Balance at Dec. 31, 2022 $ 288,871 17,892 525 (180,779) 126,509
Statement Line Items [Line Items]          
Other comprehensive loss for the year, net of taxes 0 0 (2,082) 0 (2,082)
Net loss for the year 0 0 (64,666) (64,666)
Share-based payment expense 0 1,226 0 0 1,226
Directors’ fees paid in deferred share units $ 0 595 0 0 595
Proceeds from issuance of shares, net of transaction costs (Note 13) (in shares) 4,886,364        
Proceeds from issuance of shares, net of transaction costs (Note 13) $ 14,077 5,883 0 0 19,960
Exercise of share based payment arrangement (Note 13) (in shares) 763        
Exercise of share based payment arrangement (Note 13) $ 17 (17) 0 0 0
Settlement of interest on 2028 Notes (Note 15) (in shares) 165,200        
Settlement of interest on 2028 Notes (Note 15) $ 795 0 0 0 795
Settlement of transaction costs on 2028 Notes (in shares) 19,375        
Settlement of transaction costs on 2028 Notes $ 240 0 0 0 240
Convertible Notes Conversion (Notes 11 and 13) (in shares) 92,136        
Convertible Notes Conversion (Notes 11 and 13) $ 998 0 0 0 998
2022 Private Placement transaction costs $ (284) 0 0 0 (284)
Settlement of easement (in shares) 2,500        
Settlement of easement $ 7 0 0 0 7
Balance (in shares) at Dec. 31, 2023 13,962,832        
Balance at Dec. 31, 2023 $ 304,721 25,579 (1,557) (245,445) 83,298
Statement Line Items [Line Items]          
Other comprehensive loss for the year, net of taxes 0 0 6,196 0 6,196
Net loss for the year 0 0 (29,447) (29,447)
Share-based payment expense 0 1,739 0 0 1,739
Directors’ fees paid in deferred share units $ 0 29 0 0 29
Proceeds from issuance of shares, net of transaction costs (Note 13) (in shares) 443,225        
Proceeds from issuance of shares, net of transaction costs (Note 13) $ 1,221 0 0 0 1,221
Warrants issued in connection with 2027 Notes, net of transaction costs (Note 11) $ 0 605 0 0 605
Performance based incentive payment (Note 13) (in shares) 41,314        
Performance based incentive payment (Note 13) $ 134 0 0 0 134
Exercise of share based payment arrangement (Note 13) (in shares) 151,066        
Exercise of share based payment arrangement (Note 13) $ 1,104 (1,104) 0 0 0
Settlement of interest on 2028 Notes (Note 15) (in shares) 210,760        
Settlement of interest on 2028 Notes (Note 15) $ 543 0 0 0 543
Balance (in shares) at Dec. 31, 2024 14,809,197        
Balance at Dec. 31, 2024 $ 307,723 $ 26,848 $ 4,639 $ (274,892) $ 64,318